GigCapital3, the third blank check company from semiconductor veteran Avi Katz, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. GigCapital3 is calling itself a Private-to-Public Equity (PPE) company, a term its sponsor...read more
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more
GigCapital, a blank check company formed by semiconductor veteran Avi Katz to acquire a TMT business, raised $125 million by offering 12.5 million shares at $10. It originally planned to raise $150 million. Each unit consists of one share of common stock,...read more
The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more
TMT SPAC GigCapital3 files for a $200 million IPO
GigCapital3, the third blank check company from semiconductor veteran Avi Katz, filed on Tuesday with the SEC to raise up to $200 million in an initial public offering. GigCapital3 is calling itself a Private-to-Public Equity (PPE) company, a term its sponsor...read more
US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more
Semiconducor blank check GigCapital prices downsized IPO at $10 to raise $125 million
GigCapital, a blank check company formed by semiconductor veteran Avi Katz to acquire a TMT business, raised $125 million by offering 12.5 million shares at $10. It originally planned to raise $150 million. Each unit consists of one share of common stock,...read more
US IPO Week Ahead: Two big biotechs lead 6-IPO week
The 2017 IPO market's final two-week sprint kicks off this week with six IPOs targeting $731 million. The week's three health care IPOs each have significant insider buying, one of which could be the year's largest biotech IPO by market cap, ...read more